Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Aug 7.
Published in final edited form as: Colorectal Cancer. 2012;1(5):383–396. doi: 10.2217/crc.12.45

Relationship of colorectal cancer awareness and knowledge with colorectal cancer screening

Heather M Brandt 1,*, Heather R Dolinger 2, Patricia A Sharpe 3, James W Hardin 4, Franklin G Berger 5
PMCID: PMC4529290  NIHMSID: NIHMS435631  PMID: 26257828

SUMMARY

Aim

The aim was to describe the association of awareness and knowledge with participation in colorectal cancer (CRC) screening.

Materials & methods

Telephone survey research was conducted with South Carolina (USA) residents aged 50–75 years using a 144-item instrument. Data were analyzed with SAS and Stata. Adjusted odds ratios are reported.

Results

Respondents (n = 1302) had heard of CRC screening (96%) and exhibited high levels of CRC awareness and knowledge; only 74% had ever been screened. Higher levels of knowledge were associated with a greater likelihood of having ever been screened (odds ratio: 1.05; 95% CI: 1.02–1.41; p < 0.001).

Conclusion

Results showed high levels of awareness and knowledge, but modest participation in CRC. Transforming awareness and knowledge into CRC screening participation should be a priority.


Colorectal cancer (CRC) is one of the most common, deadly and preventable types of cancer. CRC is the third most commonly diagnosed cancer and second-leading cause of cancer death in the USA [1]. Many incident cases of CRC can be prevented or have the disease downstaged through participation in recommended screening, especially colonoscopy [29]. CRC screening is vastly underutilized in comparison with other types of cancer screening [4]. Thus, higher rates of disease and death persist with significant disparities by racial and ethnic groups, particularly among African–Americans, and by geographic location (i.e., urban or rural designation), particularly among those living in rural-designated areas [14]. According to the 2008 National Health Interview Survey findings, only 52% of individuals aged 50–75 years were adherent to CRC screening recommendations [101]. The Healthy People 2020 goal is 70.5% adherence. For cervical cancer, the goal is 93% adherence with 84.5% of women (aged 21–65 years) adherent to cervical cancer screening recommendations according to the 2008 National Health Interview Survey. For breast cancer, the goal is 81.1% adherence with 73.7% of women (aged 50–74 years) adherent to breast cancer screening recommendations according to the 2008 National Health Interview Survey. Given that CRC is a deadly cancer for both men and women and CRC screening has been shown to reduce mortality, it is appropriate to explore efforts to increase participation in CRC screening.

South Carolina (USA) ranks in the highest quartile among states in overall healthcare quality, yet it ranks in the lowest quartile (i.e., biggest disparity) in income-related disparity in healthcare quality [10]. The South Carolina population represents an important, medically underserved population in which to examine participation in CRC screening, particularly among African–Americans and rural-dwelling residents.

Efforts to increase CRC screening are a priority area in cancer prevention and control. The US Department of Health and Human Services report, Health and Human Services Action Plan to Reduce Racial and Ethnic Health Disparities, identified the percentage of eligible adults who receive CRC screening (Measure 7) as a key measure to determine the success of efforts to address health disparities [11]. Preceding the Health and Human Services action report was the NIH Consensus and State-of-the-Science Statements: Enhancing Use and Quality of Colorectal Cancer Screening [12]. This report emphasized several strategies for increasing participation in CRC screening, including the use of all recommended methods for CRC screening (not only colonoscopy).

CRC screening guidelines from national organizations recommend screening for average-risk individuals beginning at age 50 years with an annual fecal occult blood test (FOBT), a flexible sigmoidoscopy or barium enema every 5 years, or a colonoscopy every 10 years [2,13]. The American College of Gastroenterology is the only national organization that recommends African–Americans to begin screening at the age of 45 years for average-risk adults due to the CRC disparities [14]. CRC screening guidelines differentiate tests that prevent disease (i.e., detect precancerous adenomatous polyps) and/or tests that detect disease [13]. Variations in screening guidelines have resulted in the development of consensus statements to provide guidance to clinicians [15]. Furthermore, CRC screening guidelines depend on personal and family history thus increasing the complexity of the recommendations.

Rates of CRC screening are incrementally increasing in the USA, but noted disparities in participation among subgroups, such as rural individuals, racial and ethnic minorities (including African–Americans), those without health insurance, those with low income levels (<US $35,000 per year) and those with less than a high school education persist [3,4,1620]. African–Americans are less likely to participate in CRC screening (62.9%) compared with their European–American/white counterparts (66.2%). The reasons for disparities in cancer screening, and specifically CRC screening, are complex and not well understood. Socioeconomic status and access to healthcare continue to be major factors in determining participation in CRC screening among African–Americans [4,16,18,2134]. Uninsured individuals continue to have the lowest levels of CRC screening, and African–Americans comprise a large proportion of the uninsured and underinsured in the USA [4,3436]. Cost, physician recommendation and regular contact with the medical system are major factors in determining participation in CRC screening, and for which African–Americans face greater barriers in financial and geographic access to care [16,23,2633,3749]. Healthcare system barriers, such as lack of healthcare provider recommendation, inadequate referral systems for screening, emphasis on management of competing comorbid conditions and insurance coverage impede uptake of CRC screening, and the role of healthcare providers and administrators in recommending participation in screening among patients negatively impacts participation [50,51]. Lower rates of CRC screening participation among African–Americans have previously been shown to be correlated with marginal levels of CRC knowledge and fatalistic beliefs and attitudes about cancer screening [18,23,25,26,30,45,5260]. CRC knowledge and participation in screening tend to be lower among individuals with lower levels of educational attainment and limited economic opportunity although the nature and influence of these contextual factors are not well studied or understood [4,18,23,26,30,51,5961]. Understanding the relationship of awareness and knowledge with CRC screening is useful to develop appropriate interventions and increase participation in CRC screening.

The aim of this study was to describe the relationship of CRC awareness and knowledge with CRC screening participation among a population-based sample of screening-age men and women (aged 50–75 years) in South Carolina.

Materials & methods

A cross-sectional, population-based, random-digit dialed telephone survey of CRC screening-age men and women (aged 50–75 years) in South Carolina was conducted in 2009. The telephone survey was administered by a professional survey research firm. Randomly selected nonrestricted landline and cellular telephone numbers with South Carolina area codes (Survey Sampling, Inc.) were automatically dialed. Eligible respondents were male and female residents of South Carolina (i.e., lived in the state the majority of the time); aged 45–75 years (focus of this analysis on screening age only, i.e., 50–75 years); had no hearing, speaking or cognitive difficulties to prevent completion of a telephone interview; and had the ability to hear, speak and respond in English. From May to August 2009, trained male and female interviewers administered a 144-item instrument using computer-assisted telephone interviewing. The 144-item instrument was designed to assess personal, social and behavioral correlates, including CRC awareness and knowledge, of participation in CRC screening. Extensive instrument development included a systematic literature review, external expert review and multiphase pretesting. Existing questionnaire items, previously used in cancer prevention and control research in South Carolina and nationwide, and newly identified items were included in the final instrument. The instrument used ‘colon cancer’ rather than ‘colorectal cancer’ due to literacy concerns identified during pretesting. The reading grade level of the instrument was 8.1. A ‘plain language’ definition of colon cancer was provided to all respondents, and ‘plain language’ definitions for other medical and technical terms (e.g., colonoscopy, polyp and Crohn’s disease) used in the instrument were included for interviewers to reference to standardize information provided to respondents and to optimize comprehension among respondents. Eligibility was determined by a series of prescreening items before beginning the survey. When eligible respondents agreed to participate in the study, respondents were asked a series of questions to confirm their understanding of what was expected of them as a respondent and to confirm that they agreed to voluntarily participate. This verbal informed consent process with a standardized interviewer script is routinely used in telephone-based survey research and was approved by the University’s Institutional Review Boards. At the end of the telephone survey, interviewers provided respondents with a toll-free number to access information on CRC and the contact information of the lead investigator (Heather M Brandt).

A total of 1532 respondents responded to the survey with 29 partial completions, which were excluded. The total sample was 1503. The average completion time was 28.5 min (range: 9–70 min). Defined as ‘completed interviews + partially completed interviews + refusals + language barrier + ill or (senile + consistent answering machines + unable to complete during fielding period + never answered numbers)’, the response rate was 36.6%. This rate is similar to the response rate for other telephone surveys with initial screening eligibility questions administered prior to enrollment [62]. A series of initial screening questions were used to assess age, South Carolina residence, gender, ethnicity and race. Once the desired proportions of respondents were enrolled, no more individuals who possessed this (these) characteristic(s) were enrolled. Because there was no information collected from nonresponders either initially or at follow-up, we could not assess whether there was a difference between responders and non-responders. As noted in the eligibility criteria, individuals meeting other eligibility requirements between the ages of 45 and 49 years were included in the sampling process to assess correlates of CRC screening prior to the recommended age of initiation of routine CRC screening. Only respondents of screening age (50–75 years) were included in the final sample (n = 1302) and analysis for this study. Sufficient statistical power was retained to assess the relationship of awareness and knowledge with screening. The survey research firm provided a technical report of data collection procedures, including response, completion, participation rates and information on US Census-weighted variables (i.e., age and race). Lastly, the survey research firm provided an error-free data file in SAS format.

Measures

The main dependent variable was self-reported participation in CRC screening, specifically undergoing screening by FOBT, flexible sigmoidoscopy and/or colonoscopy. Two dependent variables were created. If respondents indicated participation in ≥one CRC screening test, the respondent was considered ‘ever been screened’. Adherence to CRC screening was calculated using current age, age at first CRC screening test and lifetime number of tests. Adherence status was based on the type of CRC screening test.

The main independent variables were awareness and knowledge of CRC. Four awareness items and 14 knowledge items were analyzed by item and by creating a composite index score. Awareness was assessed by the following questions: “Have you ever heard of colon cancer?”, “Have you ever heard of colon cancer screening?”, “Can you name any of the screening tests for colon cancer?” and “Which colon cancer screening tests can you name?” Responses were “Yes,” “No” and “Don’t know.” Knowledge was assessed by items such as, “Colon cancer usually develops over a period of several years”, “Generally, colon cancer screening should start at age 50”, “Colon cancer starts as a polyp, which is a small growth found in the colon”, and “People eating a low fat and high fiber diet seem to have a lower risk of colon cancer.” Responses were “True,” “False” and “Don’t know.”

Analysis

Data were analyzed using SAS and Stata. Descriptive statistics summarized descriptive information about respondents and responses to awareness, knowledge and CRC screening items. Bivariate associations were examined prior to using logistic, ordered logistic and linear regression to assess the relationship of awareness and knowledge with covariates and CRC screening participation. Analyses were adjusted using sampling weights so results reflect population characteristics of the state of South Carolina; sampling weights were not adjusted for nonresponse because no information was collected about nonresponders. Odds ratios were adjusted (aOR) for race, gender, age, whether the subject has graduated from high school, whether income is over $75,000 per year, marital status, whether insured and whether from an urban setting. Statistical tests were considered significant at p ≤ 0.05. Confidence intervals (95%) were calculated. An awareness score (range: 0–4) was created by assigning +1 to each of three awareness items if the respondent answered “Yes.” One additional point was awarded if the respondent could name a screening test. A knowledge score (range: 0–14) was created by assigning +1 for every item answered correctly. “Don’t know” responses were considered to be incorrect for the knowledge score.

The knowledge and awareness scores were analyzed using ordered logistic and linear regression models with no difference in inference. Inference outside of the range of covariates could imply scores outside of the possible range, but since all covariates are discrete this is not an issue and inference is in terms of means for covariate patterns. While there was some evidence of heteroskedasticity, there was no evidence of collinearity (all variance inflation factors were less than 1.5), no evidence of missing covariates and no evidence that the identity link was inappropriate. The knowledge scores are skewed overall, but not for the individual covariate patterns. Thus, the data satisfied the assumptions for interpretation in a linear regression setting.

Results

Respondents (n = 1302) were mostly female (63%), European–American (77%), had at least some college education (59%), were married or lived with a partner (62%) and had some type of health insurance (81%). The mean age of respondents was 60.3 (standard deviation [SD]: 8.6; range: 50–75) years. For selected descriptive characteristics of respondents, the 2000 US Census estimates for the South Carolina population (2008 updated at time of study) are provided to show comparison between the respondents and the population base. It is important to note that race and ethnicity were asked separately, and the low proportion of Hispanic or Latino/a respondents did not allow for further subgroup analysis by ethnicity. Descriptive characteristics of respondents are shown in Table 1.

Table 1.

Descriptive characteristics of respondents (n = 1302).

Characteristic f % South Carolina (USA) population, 2000 (2008 updated as available) (%)
Gender
Male 483 37 49
Female 819 63 51
Ethnicity: Hispanic or Latino/a (Yes) 22 2 3
Race
African–American/black 275 21 29
European–American/white 1003 77 69
Other 24 2 2
Age (mean = 60, SD = 8.6; years)
50–54 250 19 19 (45–59)
55–59 242 19
60–64 267 21 11 (60–74)
65–75 543 41
Education
Less than high school diploma 177 14 24
High school diploma or GED 360 28 30
Some college 283 22 19
College degree 471 36 20
Unknown 11 <1
Income
Less than US$25,000 322 25 25
US$25,000–49,999 307 24 32
US$50,000–74,999 192 15 22
More than US$75,000 260 20 21
Unknown 221 17
Relationship status
Single 92 7 26
Partner/married 792 61 54
Separated/divorced/widowed 408 31 20
Unknown 10 <1
Insurance status and type
Insured 1194 92 81
Uninsured 108 8 19
Geographic location
Urban 849 65 60
Rural 453 35 40

US Census data available at the time of survey administration (2009) provided for comparison.

f: Frequency; GED: General educational development; SD: Standard deviation.

Bivariate comparisons between descriptive characteristics shown in Table 1 by main outcome variables are provided in Table 2. For ‘ever been screened’, age, relationship status and insurance status were significant. For ‘adherence to any screening method’, race, age, whether the subject has graduated from high school, whether income is greater than $75,000 per year, marital status and whether the subject has insurance were significantly associated. For the knowledge score, gender, race, education, income, insurance status, and urban or rural designation were significant.

Table 2.

Bivariate comparisons between descriptive characteristics and outcome variables (p-values).

Descriptive characteristic Outcome variables
Ever been screened Adherent to screening Knowledge score
Gender 0.305 0.190 0.001*
Race 0.155 0.005* <0.001*
Age <0.001* <0.001* 0.145
Education 0.416 0.025* <0.001*
Income 0.180 <0.001* <0.001*
Relationship status 0.011* 0.003* 0.264
Insurance status <0.001* <0.001* 0.002*
Geographic location 0.222 0.164 0.005*
*

Statistically significant at p ≤ 0.05.

Awareness items are shown in Table 3. The majority of respondents had heard of CRC (91%). Of those who had heard of colon cancer, the majority had heard of CRC screening (96%). More than half of the respondents (62%) said they could name a CRC screening test. The most common CRC screening test named was the colonoscopy (90%), followed by FOBT (20%) and flexible sigmoidoscopy (14%). The mean awareness score was 3.0 (SD: ±1.4) with the majority of respondents having an awareness score of 3.0 (62%).

Table 3.

Awareness of colorectal cancer and colorectal cancer screening.

Awareness item Yes %
Have you ever heard of colon cancer, sometimes called colorectal cancer? 1185 91
Have you ever heard of colorectal cancer screening? 1139 96
Can you name any of the tests for colon cancer? 811 62
Which colon cancer screening test can you name?§ Named the test option
Colonoscopy 732 90
Fecal occult blood test 162 20
Flexible sigmoidoscopy 113 14
Some other test(s) not named above, e.g., barium enema and virtual colonoscopy 111 13
Awareness score (0–4) f %
0 117 9
1 46 4
2 328 25
3 811 62
4 763 59
Awareness score: mean = 3.0 (SD ± 1.4)

Frequencies and percentages are from tabulations using survey weights to ensure generalizability to the South Carolina (USA) population.

Question was only asked to those who answered “Yes” to ever heard of colon cancer; excluded five “Don’t know” responses (n = 1185).

Question was only asked to those who answered “Yes” to ever heard of colon cancer and answered “Yes” to ever heard of colon cancer screening; excluded 25 “Don’t know” responses (n = 1139).

§

Question was answered only by those who said “Yes” to can you name any of the screening tests and preceding two items (n = 811).

f: Frequency; SD: Standard deviation.

Knowledge items are shown in Table 4. The three knowledge items with the highest percentage of correct responses were: “Colon cancer starts as a polyp, which is a small growth found in the colon” (~100% answered “True”), “A colonoscopy is the most accurate test to check for polyps in the colon and rectum” (99% answered “True”), and “People who have a family history of colon cancer tend to have a lower risk of colon cancer (94% answered “False”). The item with the lowest percentage of correct answers was: “Colon cancer is most often caused by a person’s behavior or lifestyle” (30% answered “True”). Two items had “Don’t know” responses >25%: “African–Americans should start screening at age 45” (27% answered “Don’t know”) and “People with high alcohol consumption seem to have a lower risk of colon cancer” (27% answered “Don’t know”). The mean knowledge score was 9.6 (SD: ±3.8) with 46% of respondents correctly answering between eight and 11 items. CRC screening participation is shown in Table 5. Seventy four percent of respondents who had had any of the three CRC screening tests were included in this analysis. The most common screening test was colonoscopy (70%) followed by FOBT (35%) and flexible sigmoidoscopy (31%).

Table 4.

Knowledge of colorectal cancer and colorectal cancer screening.

Knowledge item Total f (%)
True False Don’t know
People with colon cancer have symptoms before being diagnosed 232 (18) 868 (67) 202 (16)
Colon cancer usually develops over a period of several years 839 (64) 187 (14) 276 (21)
There are ways to stop the development of colon cancer 931 (72) 115 (09) 256 (20)
Colon cancer is most often caused by a person’s behavior or lifestyle 314 (24) 743 (57) 245 (19)
Generally, colon cancer screening should start at age 50 869 (67) 270 (21) 163 (13)
African–Americans should start screening at age 45 704 (54) 130 (8) 495 (38)
Colon cancer starts as a polyp, which is a small growth found in the colon 1152 (88) 6 (<1) 144 (11)
A colonoscopy is the most accurate test to check for polyps in the colon and rectum 1122 (86) 15 (1) 165 (13)
People eating a low-fat and high-fiber diet seem to have a lower risk of colon cancer 986 (76) 84 (6) 232 (18)
People with high alcohol consumption seem to have a lower risk of colon cancer 70 (5) 758 (558) 474 (36)
People who do not exercise seem to have a lower risk of colon cancer 130 (10) 884 (68) 288 (22)
People who have high levels of stress tend to have a lower risk of colon cancer 81 (6) 944 (73) 277 (21)
People who are overweight tend to have a lower risk of colon cancer 68 (5) 997 (77) 237 (18)
People who have a family history of colon cancer tend to have a lower risk of colon cancer 67 (5) 1072 (82) 163 (13)
Knowledge score (0–14) f %
0–3 137 11
4–7 106 8
8–11 597 46
12–14 462 35
Knowledge score: mean = 9.6 (SD ± 3.8)

Frequencies and percentages are from tabulations using survey weights to ensure generalizability to the South Carolina (USA) population.

“Don’t know” responses were considered incorrect when calculating the knowledge score.

f: Frequency; SD: Standard deviation.

Table 5.

Colorectal cancer screening history (n = 1302).

CRC screening test Total f (%)
Physician recommended
Ever had test
Abnormal test
f % f % f %
Any screening test 1137 87 1114 74 328 25

FOBT 721 55 451 35 89 7

Flexible sigmoidoscopy 428 33 403 31 49 4

Colonoscopy 989 76 905 70 248 27

Frequencies and percentages are from tabulations using survey weights to ensure generalizability to the South Carolina (USA) population.

CRC: Colorectal cancer; f: Frequency; FOBT: Fecal occult blood test.

Logistic regression of CRC screening tests by awareness score and knowledge score is shown in Table 6. A one-unit increase in awareness score significantly increased the odds of respondents being more likely to have had any screening test (aOR: 1.43; 95% CI: 1.30–1.59; p < 0.001), colonoscopy (aOR: 1.43; 95% CI: 1.29–1.57; p < 0.001), flexible sigmoidoscopy (aOR: 1.27; 95% CI: 1.13–1.41; p < 0.001), or FOBT (aOR: 1.13; 95% CI: 1.02–1.25; p = 0.016). A one-unit increase in knowledge score significantly increased the odds of respondents being more likely to have had any screening test (aOR: 1.06; 95% CI: 1.02–1.09; p = 0.004), FOBT (aOR: 1.04; 95% CI: 1.00–1.07; p = 0.043), or colonoscopy (aOR: 1.05; 95% CI: 1.02–1.10; p = 0.003). A one-unit increase in knowledge score increased the odds of respondents being more likely to have had a flexible sigmoidoscopy (aOR: 1.04; 95% CI: 1.00–1.07; p = 0.054) although these results were not significant. In all of these results relating one-unit increases in knowledge scores to the likelihood of various outcomes, a one-unit increase reflects one additional correct answer. An aOR of 1.06 for any screening method relative to knowledge indicates that, on average, persons who correctly answer one additional question have 1.06-times the odds of getting screened for CRC. Furthermore, these effects are multiplicative. On average, persons who answer four more questions correctly have 1.064 = 1.26 times the odds of getting screened. Thus, although statistical significance is presented for the average difference (in terms of aOR) for a one-unit increase, a novel intervention may target a practical difference reflecting an increase of several correct questions on average.

Table 6.

Logistic regression of colorectal cancer screening test by awareness and knowledge scores.

CRC screening test Awareness score
Knowledge score
aOR (95% CI) p-value aOR (95% CI) p-value
Any screening test 1.43 (1.30–1.59) <0.001* 1.06 (1.02–1.09) 0.004*

FOBT 1.13 (1.02–1.25) 0.016* 1.04 (1.00–1.07) 0.043*

Flexible sigmoidoscopy 1.27 (1.13–1.41) <0.001* 1.04 (1.00–1.07) 0.054

Colonoscopy 1.43 (1.29–1.57) <0.001* 1.05 (1.02–1.10) 0.003*

Odds ratios were adjusted for race, gender, age, whether the subject has graduated from high school, whether income is over US$75,000 per year, marital status, insurance status and whether from an urban setting. Model results used survey weights to ensure generalizability to the South Carolina (USA) population.

*

Statistically significant at p ≤ 0.05.

aOR: Adjusted odds ratio; CRC: Colorectal cancer; FOBT: Fecal occult blood test.

Logistic regression of having any CRC screening test and colonoscopy was compared by awareness score and knowledge score (Table 7). Respondents who had heard of a colonoscopy had greater odds of having had any CRC screening test (aOR: 1.71; 95% CI: 1.06–2.76; p = 0.028) and of having had a colonoscopy (aOR: 1.59; 95% CI: 1.03–2.45; p = 0.34). Respondents who could name at least one CRC screening test had greater odds of having had any CRC screening test (aOR: 3.74; 95% CI: 2.76–5.08; p < 0.001) and of having had a colonoscopy (aOR: 3.69; 95% CI: 2.83–4.82; p < 0.001). A one-unit increase in awareness score was significantly associated with increased odds of having any CRC screening test (aOR: 1.44; 95% CI: 1.30–1.59; p < 0.001) and of having had a colonoscopy (aOR: 1.43; 95% CI: 1.29–1.57; p = 0.002). A one-unit increase in knowledge score was significantly associated with increased odds of having any CRC screening test (aOR: 1.05; 95% CI: 1.02–1.10; p = 0.004) and of having had a colonoscopy (aOR: 1.05; 95% CI: 1.02–1.09; p = 0.003).

Table 7.

Logistic regression of having any colorectal cancer screening test and colonoscopy by awareness and knowledge.

More likely to have had any CRC screening test
More likely to have had a colonoscopy
aOR (95% CI) p-value aOR (95% CI) p-value
Ever heard of colonoscopy 1.71 (1.06–2.76) 0.028* 1.59 (1.03–2.45) 0.034*

Named at least one CRC screening test 3.74 (2.76–5.08) <0.001* 3.69 (2.83–4.82) <0.001*

One unit increase in awareness score 1.44 (1.30–1.59) <0.001* 1.43 (1.29–1.57) 0.002*

One unit increase in knowledge score 1.05 (1.02–1.10) 0.004* 1.05 (1.02–1.09) 0.003*
*

Statistically significant at p ≤ 0.05.

Odds ratios were adjusted for race, gender, age, whether the subject has graduated from high school, whether income is over US$75,000 per year, marital status, insurance status and whether from an urban setting. Model results used survey weights to ensure generalizability to the South Carolina (USA) population.

aOR: Adjusted odds ratio; CRC: Colorectal cancer.

Table 8 shows logistic, ordered logistic and linear regression (as noted) results of the awareness score, knowledge score and CRC screening tests (any of the three CRC screening tests, FOBT, flexible sigmoidoscopy and colonoscopy) by gender, race, urban or rural designation, age, education, income, relationship status and insurance status. A number of statistically significant observations were identified. Significant differences in knowledge scores were observed between African–American and European–American respondents (lower knowledge among African–American respondents) and by level of education (lower knowledge among those who had not graduated from high school). Awareness scores were significantly lower among males, African–Americans and those who had not graduated from high school. African–American respondents were significantly more likely than European–American respondents to have had a FOBT. Flexible sigmoidoscopy was more common among older respondents and those who did not have insurance. Colonoscopy was significantly less likely among males, African–Americans, respondents living in rural-designated areas, those with younger age, those who had not graduated from high school and those without insurance.

Table 8.

Awareness, knowledge and colorectal cancer screening test by gender, race and urban or rural designation.

Knowledge score Awareness score Any screening test FOBT Flexible sigmoidoscopy Colonoscopy
β-Coef (95% CI); p-value aOR (95% CI); p-value aOR (95% CI); p-value aOR (95% CI); p-value aOR (95% CI); p-value aOR (95% CI); p-value
Male −0.42 (−0.87–0.04) 0.20 (0.31–0.9) 0.86 (0.64–1.17) 0.96 (0.74–1.24) 1.11 (0.85–1.44) 0.73 (0.55–0.95)
0.073 0.001* 0.346 0.757 0.434 0.021*

African–American vs European–American/white −1.62 (−2.25 to −1.00) 0.45 (−0.60–0.30) 0.90 (0.62–1.30) 1.76 (1.29–2.39) 1.24 (0.88–1.73) 0.71 (0.52–0.98)
<0.001* <0.001* 0.567 <0.001* 0.215 0.037*

Urban −0.02 (−0.47–0.43) −0.60 (−0.16–0.05) 1.23 (0.90–1.69) 0.83 (0.64–1.08) 0.94 (0.71–1.24) 1.33 (1.02–1.76)
0.945 0.310 0.199 0.172 0.680 0.017*

Age −0.36 (−0.83–0.11) −0.04 (−0.16–0.07) 1.94 (1.41–2.68) 1.18 (0.91–1.52) 1.82 (1.40–2.37) 1.67 (1.27–2.19)
0.137 0.443 <0.001* 0.205 <0.001* <0.001*

Education 1.67 (1.12–2.20) 0.44 (0.31–0.57) 1.27 (0.91–1.75) 1.21 (0.93–1.59) 1.25 (0.94–1.67) 1.44 (1.08–1.91)
<0.001* <0.001* 0.147 0.162 0.120 0.012*

Income 0.51 (−0.06–1.09) 0.09 (−0.51–0.23) 1.12 (0.72–1.72) 1.28 (0.91–1.80) 1.31 (0.93–1.84) 0.91 (0.63–1.33)
0.082 0.213 0.621 0.155 0.121 0.636

Relationship status 0.06 (−0.42–0.53) −0.02 (−0.13–0.10) 0.93 (0.67–1.29) 0.97 (0.74–1.26) 1.16 (0.89–1.53) 1.11 (0.84–1.48)
0.818 0.775 0.681 0.797 0.274 0.488

Insurance status −0.21 (−1.00–0.58) 0.05 (−0.14–0.23) 2.63 (1.67–4.17) 1.41 (0.87–2.30) 2.27 (1.27–4.05) 2.84 (1.81–4.48)
0.606 0.606 <0.001* 0.158 0.006* <0.001*

Model results used survey weights to ensure generalizability to the South Carolina (USA) population.

Linear regression coefficients are listed for the knowledge score model. aORs (race, gender, age, whether graduated from high school, whether income is over US$75,000 per year, marital status, insurance status and whether from an urban setting) are reported for models of awareness score and colorectal cancer screening tests. Ordered logistic regression was used for awareness score models. Logistic regression was used for models of colorectal cancer screening tests.

*

Statistically significant at p < 0.05.

aOR: Adjusted odds ratio; Coef: Coefficient; FOBT: Fecal occult blood test.

Discussion

This study was the largest cross-sectional study of CRC screening among screening-age adults in South Carolina to date and provides information that may also be useful to other states in southeastern USA where CRC screening participation is lower than ideal and confounded by social determinants indicative of disparities in CRC disease outcomes. The final sample for this study had a higher proportion of females, was older, had higher levels of education and was more likely to be married compared with the population characteristics of the state of South Carolina. This is somewhat expected given the limited age range of eligible respondents (i.e., 50–75 years) and based on previous telephone survey research [62,63]. Sampling weights were used to increase the representativeness of the study sample to the state to increase the validity of findings.

CRC screening participation among respondents was higher than recently reported rates for South Carolina. In this study, 74% of respondents reported ever being screened for CRC with the majority (70%) indicating colonoscopy. Recent data show 66% of South Carolinians have had an FOBT in the past year and/or lower endoscopy in the past 10 years [4]. We defined adherence using guidelines for number of screening examinations over time for each screening test and constructed an indicator variable for each screening test and for having adhered to any of the screening guidelines. It is also recognized that ‘ever having been screened’ rates are likely to be higher than those for adherence to recommended screening guidelines. Given the noted benefits of CRC screening tests that detect precancerous polyps and can prevent incident cases, there is concern about the mode of testing by race in this study. African–American respondents were more likely to have had a FOBT and less likely to have had a colonoscopy compared with European–American respondents. Data not shown indicate that African–American respondents were more likely to report physician recommendation for FOBT compared with colonoscopy, and this could be an important system-level factor deserving of further study and intervention [64]. Differences by urban or rural designation were most notable in subjects ‘ever having had a colonoscopy’ with urban respondents being more likely than rural respondents. African–Americans and rural residents stand to benefit greatly from increased access to colonos-copy and the ability to prevent incident cases of CRC, yet our study shows lower participation and great opportunity for further examination of facilitators and barriers to increase participation in colonoscopy, in particular.

Awareness scores and knowledge scores indicated high levels of CRC awareness and knowledge among respondents. Awareness and knowledge were positively linked to increased likelihood of ever being screened for CRC and adherence to CRC screening recommendations for the full sample. This is consistent with previously reported findings showing a positive correlation between awareness and knowledge and participation in CRC screening, including differences in CRC screening participation by race [18,25,26,30,47,5456,5860,65]. Differences by race were observed in this study when comparing African–American and European–American respondents. African–American respondents had lower levels of CRC awareness and knowledge compared with European–American respondents. Approaches to increase participation in CRC screening among groups experiencing persistently higher rates of CRC incidence and mortality in light of overall declines in CRC incidence and mortality are urgently needed so that everyone benefits. The differences in awareness and knowledge between African–American respondents and European–American respondents may point to the need for culturally appropriate and culturally targeted interventions to increase participation in CRC screening.

CRC screening recommendations vary by organization, which could contribute to confusion on behalf of consumers. Because CRC screening guidelines have increased in complexity, it is unknown whether guidelines are fully understood by those in the recommended age range for screening. The American College of Gastroenterology recommends starting screening at 45 years of age for African–Americans and 50 years of age for the rest of the general populations. Other organizations recommend screening starting at 50 years of age for all average-risk individuals. Overall, all organizations recommend having a colonoscopy every 10 years, a flexible sigmoidoscopy (concurrently with an FOBT or alone) every 5 years or an FOBT annually. This warrants monitoring and additional study.

Culturally targeted interventions to increase participation in CRC screening have been successful previously and are recommended [12,51,53,61,6673]. The Community Guide includes recommendations for client-oriented and provider-oriented strategies inclusive of efforts to address awareness and knowledge in addition to increasing actions, in this case CRC screening, that are appropriate for cultural targeting [74]. Specifically for increasing CRC screening, recommended client-oriented strategies for which sufficient evidence exists to support intervention include client reminders (e.g., follow-up telephone or mailed print reminders about screening), small media (e.g., printed brochures), one-on-one education (e.g., conversations between a healthcare provider, health educator or lay health advisor and an individual due for screening), and reducing structural barriers (e.g., reducing time/distance to a facility for screening, modifying hours of service and simplifying administrative procedures) [74]. Recommendations for provider-oriented strategies include provider assessment and feedback (e.g., provide information on quality of screening services provided and proportion of eligible patients receiving recommended screenings as appropriate) and provider reminder and recall systems (e.g., cues to alert providers that a patient is due for screening) [74]. Each of the recommended strategies includes awareness and educational components addressing knowledge and subsequent action that could positively contribute to increased participation in CRC screening.

While not a main focus of the study, it is important to note the role of access to care in adherence to CRC screening recommendations. In this study, insurance status was significantly associated with having had any CRC screening test, flexible sigmoidoscopy and colonoscopy, which shows a strong correlation between having insurance coverage and being screened. This is expected given the high proportion of respondents with insurance coverage, mostly Medicare due to the older age of the sample. Access to care is a multidimensional concept that extends beyond merely having a physical place to be screened. Access to care encompasses affordability, availability, accessibility, accommodation and acceptability [48,49]. The Patient Protection and Affordable Care Act will address financial access (i.e., affordability) for preventive services, such as CRC screening, and may address other dimensions of access to care. However, it seems clear that additional efforts will be needed most likely to examine and intervene appropriately to ensure availability, accessibility, accommodation and acceptability in order to address shortcomings in CRC screening. Awareness and knowledge play a role in facilitating access to care, and such efforts to make connections to CRC screening are an equally important part of future intervention efforts to increase participation in CRC screening.

Limitations

The cross-sectional design of the study allowed for a snapshot of relationships between awareness and knowledge and participation in CRC screening. As a result, it was impossible to determine the direction of influence in our analyses as would be possible in a prospective study design. While the population-based approach to sampling and large sample size were strengths of this study, sampling weights were used to adjust for demographic characteristics of the study sample that were slightly different from South Carolina as a whole. The survey was long (144 items) and on average required just under 30 min to complete (28.5 min). This may have affected the response rate. In addition, using a targeted sampling approach may have also impacted the response rate. The response rate was 36.6%, which is similar to other computer-assisted telephone interviewing response rates from household phones [62]. Unfortunately, there is no way to determine if there was a difference between responders and nonresponders due to the sampling procedures for a narrow sample population. For example, once the desired proportion of European–Americans was reached, no more individuals identifying as European–American were included. It is also important to note that telephone survey methodology has inherent limitations, but methods were employed to maximize participation [62,63]. The survey research firm utilized the Behavioral Risk Factor Surveillance Survey (CDC) methodology for random-digit dial surveys to contact potential respondents on all days of the week during a wide range of calling hours [75]. Additional challenges that may have affected the response rate were answering machines and caller identification, which can reduce the response rate [62,63]. Self-reported participation in CRC screening may be considered a limitation, but self-reported participation in cancer screening has shown ‘dependable agreement’ with provider report, medical records review and health insurance claims data [7679].

Conclusion & future perspective

Based on our results, levels of CRC awareness and knowledge among our South Carolina respondents were relatively high, yet participation in CRC screening was not commensurate. Disparities by race, gender, urban or rural designation, educational level and age in awareness, knowledge and/or participation in CRC screening existed and confirmed previous reports. It is also reasonable to assume that dimensions of access to care are important factors when examining participation in CRC screening [48,49]. While awareness and knowledge of CRC screening may be critical pre cursors and components of undergoing screening, awareness and knowledge alone may be insufficient for increasing overall participation in CRC screening, especially for African–Americans and rural populations, to the levels of participation in screening for other types of cancer. Approaches to addressing attitudinal and system-level barriers that impact the application of high levels of CRC awareness and knowledge to CRC screening are needed. Our findings support recommendations for targeting interventions to the characteristics and preferences of a target population to increase participation in CRC screening. Additional research is needed to further examine the relationship between awareness and knowledge and timeliness and adherence to CRC screening intervals.

Summary points.

  • Despite the ability to prevent the development of colorectal cancer (CRC) and downstage disease, the participation in CRC screening lags behind screening for other types of cancer.

  • CRC awareness and knowledge have been shown to be positively associated with participation in screening, and there has been significant focus on addressing awareness and knowledge in CRC intervention research.

  • In our study, CRC awareness and knowledge levels were high overall, yet participation in CRC screening was modest.

  • Awareness and knowledge levels and CRC screening participation were lower in African–American respondents compared with white respondents. Culturally appropriate and culturally targeted efforts to increase awareness and knowledge, while facilitating participation in CRC screening, may be productive.

  • Awareness levels and participation in colonoscopy were lower in rural-dwelling respondents compared with urban respondents, which may reflect access to CRC screening issues among rural-dwelling respondents.

  • Future interventions should focus on transforming CRC awareness and knowledge into CRC screening through recommended strategies, such as client- and provider-oriented intervention strategies recommended in The Community Guide, and strategies documented in recent reviews of successful cancer screening interventions by addressing attitudinal and system-level factors.

Footnotes

Disclaimer

The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Ethical conduct of research

The authors received verbal informed consent over the telephone from respondents for this study, per their research protocol (University of South Carolina IRB tracking #Pro00002697).

Financial & competing interests disclosure

This research was supported by the Center for Colon Cancer Research (Center of Biomedical Research Excellence) grant (P20 RR17698; PI to FG Berger) through a target principal investigator award to HM Brandt. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

References

Papers of special note have been highlighted as:

▪ of interest

  • 1.U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2006 incidence and mortality pre-release data. 2010. [Google Scholar]
  • 2.U S. Preventive Services Task Force. Screening for colorectal cancer: U.S Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–637. doi: 10.7326/0003-4819-149-9-200811040-00243. [DOI] [PubMed] [Google Scholar]
  • 3.Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–249. doi: 10.3322/caac.20006. [DOI] [PubMed] [Google Scholar]
  • 4.Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC. Colorectal cancer screening – United States, 2004, 2006, and 2008. MMWR Surveill Summ. 2011;60(Suppl):42–46. [PubMed] [Google Scholar]
  • 5.Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696. doi: 10.1056/NEJMoa1100370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1–8. doi: 10.7326/0003-4819-150-1-200901060-00306. [DOI] [PubMed] [Google Scholar]
  • 7.Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann Intern Med. 2009;150:50–52. doi: 10.7326/0003-4819-150-1-200901060-00308. [DOI] [PubMed] [Google Scholar]
  • 8.Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. The reduction in colorectal cancer mortality after colonoscopy varies by site and cancer. Gastroenterology. 2010;139:1128–1137. doi: 10.1053/j.gastro.2010.06.052. [DOI] [PubMed] [Google Scholar]
  • 9.Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154:22–30. doi: 10.7326/0003-4819-154-1-201101040-00004. [DOI] [PubMed] [Google Scholar]
  • 10.Agency for Healthcare Research and Quality. National Health Care Quality Report 2011. AHRQ Publication No 12-0005. 2012;2:12–14. 110. [Google Scholar]
  • 11.US Department of Health and Human Services. HHS Action Plan to Reduce Racial and Ethnic Health Disparities: a Nation Free of Disparities in Health and Health Care. Washington, DC, USA: 2011. [Google Scholar]
  • 12.Steinwachs D, Allen JD, Barlow WE, et al. National Institutes of Health State-of-the-Science Conference Statement: Enhancing Use and Quality of Colorectal Cancer Screening. Ann Intern Med. 2010;27(1):1–31. doi: 10.7326/0003-4819-152-10-201005180-00237. [DOI] [PubMed] [Google Scholar]
  • 13.Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2012;62:129–142. doi: 10.3322/caac.20143. [DOI] [PubMed] [Google Scholar]
  • 14.Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] Am J Gastroenterol. 2009;104(3):739–750. doi: 10.1038/ajg.2009.104. [DOI] [PubMed] [Google Scholar]
  • 15.Qaseem A, Denberg TD, Hopkins RH, Jr, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156(5):378–386. doi: 10.7326/0003-4819-156-5-201203060-00010. [DOI] [PubMed] [Google Scholar]
  • 16.Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50(1–2):3–10. doi: 10.1016/j.ypmed.2009.12.005. [DOI] [PubMed] [Google Scholar]
  • 17.Baldwin LM, Cai Y, Larson EH, et al. Access to cancer services for rural colorectal cancer patients. J Rural Health. 2008;24(4):390–399. doi: 10.1111/j.1748-0361.2008.00186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18▪.McAlearney AS, Reeves KW, Dickinson SL, et al. Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer. 2008;112(2):391–398. doi: 10.1002/cncr.23156. Examines colorectal cancer screening in a population of low-income women demonstrating a clear link between screening and knowledge. The authors implore additional efforts to address gaps in knowledge in order to increase colorectal cancer screening. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Soneji S, Iyer SS, Armstrong K, Asch DA. Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. Am J Pub Health. 2010;100(10):1912–1916. doi: 10.2105/AJPH.2009.184192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Geller BM, Skelly JM, Dorwaldt AL, Howe KD, Dana GS, Flynn BS. Increasing patient/physician communications about colorectal cancer screening in rural primary care practices. Med Care. 2008;46(9 Suppl 1):S36–S43. doi: 10.1097/MLR.0b013e31817c60ea. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jerant A, Fenton J, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med. 2008;168(12):1317–1324. doi: 10.1001/archinte.168.12.1317. [DOI] [PubMed] [Google Scholar]
  • 22.Goy J, Rosenberg MW, King WD. Health risk behaviors: examining social inequalities in bladder and colorectal cancers. Ann Epidemiol. 2008;18(2):156–162. doi: 10.1016/j.annepidem.2007.09.004. [DOI] [PubMed] [Google Scholar]
  • 23.Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30(4):313–319. doi: 10.1016/j.amepre.2005.11.006. [DOI] [PubMed] [Google Scholar]
  • 24.O’malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165(18):2129–2135. doi: 10.1001/archinte.165.18.2129. [DOI] [PubMed] [Google Scholar]
  • 25.Power E, Van Jaarsveld CH, McCaffery K, Miles A, Atkin W, Wardle J. Understanding intentions and action in colorectal cancer screening. Ann Behav Med. 2008;35(3):285–294. doi: 10.1007/s12160-008-9034-y. [DOI] [PubMed] [Google Scholar]
  • 26▪.Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100(10):2093–2103. doi: 10.1002/cncr.20276. Examines predictors of colorectal cancer screening using National Health Interview Survey data. Awareness and knowledge were found to be important determinants of colorectal cancer screening and important opportunities for intervention. [DOI] [PubMed] [Google Scholar]
  • 27.Griffith KA. Biological, psychological and behavioral, and social variables influencing colorectal cancer screening in African Americans. Nurs Res. 2009;58(5):312–320. doi: 10.1097/NNR.0b013e3181ac143d. [DOI] [PubMed] [Google Scholar]
  • 28.James AS, Hall S, Greiner KA, Buckles D, Born WK, Ahluwalia JS. The impact of socioeconomic status on perceived barriers to colorectal cancer testing. Am J Health Promot. 2008;23(2):97–100. doi: 10.4278/ajhp.07041938. [DOI] [PubMed] [Google Scholar]
  • 29.Palmer RC, Midgette LA, Dankwa I. Colorectal cancer screening and African Americans: findings from a qualitative study. Cancer Control. 2008;15(1):72–79. doi: 10.1177/107327480801500109. [DOI] [PubMed] [Google Scholar]
  • 30.Post DM, Katz ML, Tatum C, Dickinson SL, Lemeshow S, Paskett ED. Determinants of colorectal cancer screening in primary care. J Cancer Educ. 2008;23(4):241–247. doi: 10.1080/08858190802189089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Purnell JQ, Katz ML, Andersen BL, et al. Social and cultural factors are related to perceived colorectal cancer screening benefits and intentions in African Americans. J Behav Med. 2010;33(1):24–34. doi: 10.1007/s10865-009-9231-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Robinson JM, Shavers V. The role of health insurance coverage in cancer screening utilization. J Health Care Poor Underserved. 2008;19(3):842–856. doi: 10.1353/hpu.0.0048. [DOI] [PubMed] [Google Scholar]
  • 33.Stacy R, Torrence WA, Mitchell CR. Perceptions of knowledge, beliefs, and barriers to colorectal cancer screening. J Cancer Educ. 2008;23(4):238–240. doi: 10.1080/08858190802189030. [DOI] [PubMed] [Google Scholar]
  • 34.Shavers VL, Jackson MC, Sheppard VB. Racial/ethnic patterns of uptake of colorectal screening, National Health Interview Survey 2000–2008. J Natl Med Assoc. 2010;102(7):621–635. doi: 10.1016/s0027-9684(15)30640-4. [DOI] [PubMed] [Google Scholar]
  • 35.Trivers KF, Shaw KM, Sabatino SA, Shapiro JA, Coates RJ. Trends in colorectal cancer screening disparities in people aged 50–64 years, 2000–2005. Am J Prev Med. 2008;35(3):185–193. doi: 10.1016/j.amepre.2008.05.021. [DOI] [PubMed] [Google Scholar]
  • 36.Denavas-Walt C, Proctor BD, Smith JC US Census Bureau. Current Population Reports, P60–239: Income, Poverty, and Health Insurance Coverage in the United States: 2010. US Government Printing Office; Washington, DC, USA: 2011. [Google Scholar]
  • 37.Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41(1):23–29. doi: 10.1016/j.ypmed.2004.11.004. [DOI] [PubMed] [Google Scholar]
  • 38.Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med. 2003;37(6 Pt 1):627–634. doi: 10.1016/j.ypmed.2003.09.016. [DOI] [PubMed] [Google Scholar]
  • 39.Katz ML, James AS, Pignone MP, et al. Colorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communication. BMC Public Health. 2004;4:62. doi: 10.1186/1471-2458-4-62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Taylor V, Lessler D, Mertens K, et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc. 2003;95(9):806–812. [PMC free article] [PubMed] [Google Scholar]
  • 41.Coughlin SS, Thompson T. Physician recommendation for colorectal cancer screening by race, ethnicity, and health insurance status among men and women in the United States, 2000. Health Promot Pract. 2005;6(4):369–378. doi: 10.1177/1524839905278742. [DOI] [PubMed] [Google Scholar]
  • 42.Berkowitz Z, Hawkins NA, Peipins LA, White MC, Nadel MR. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc. 2008;56(2):307–314. doi: 10.1111/j.1532-5415.2007.01547.x. [DOI] [PubMed] [Google Scholar]
  • 43.Brawarsky P, Brooks DR, Mucci LA, Wood PA. Effect of physician recommendation and patient adherence on rates of colorectal cancer testing. Cancer Detect Prev. 2004;28(4):260–268. doi: 10.1016/j.cdp.2004.04.006. [DOI] [PubMed] [Google Scholar]
  • 44.Guerra CE, Schwartz JS, Armstrong K, Brown JS, Halbert CH, Shea JA. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med. 2007;22(12):1681–1688. doi: 10.1007/s11606-007-0396-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Lasser KE, Ayanian JZ, Fletcher RH, Good MJ. Barriers to colorectal cancer screening in community health centers: a qualitative study. BMC Fam Pract. 2008;9:15. doi: 10.1186/1471-2296-9-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L. Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women. Cancer. 2006;106(3):664–669. doi: 10.1002/cncr.21660. [DOI] [PubMed] [Google Scholar]
  • 47.Shokar NK, Carlson CA, Weller SC. Factors associated with racial/ethnic differences in colorectal cancer screening. J Am Board Fam Med. 2008;21(5):414–426. doi: 10.3122/jabfm.2008.05.070266. [DOI] [PubMed] [Google Scholar]
  • 48.McLaughlin CG, Wyszewianski L. Access to care: remembering old lessons. Health Serv Res. 2002;37(6):1441–1443. doi: 10.1111/1475-6773.12171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19(2):127–140. doi: 10.1097/00005650-198102000-00001. [DOI] [PubMed] [Google Scholar]
  • 50.Hamlyn S. Reducing the incidence of colorectal cancer in African Americans. Gastroenterol Nurs. 2007;31(1):39–42. doi: 10.1097/01.SGA.0000310935.39304.6d. [DOI] [PubMed] [Google Scholar]
  • 51.Rawl SM, Menon U, Burness A, Breslau ES. Interventions to promote colorectal cancer screening: an integrative review. Nurs Outlook. 2012;60(4):172–181. doi: 10.1016/j.outlook.2011.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Powe BD. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs. 1995;18(5):385–392. [PubMed] [Google Scholar]
  • 53.Morgan PD, Fogel J, Tyler ID, Jones JR. Culturally targeted educational intervention to increase colorectal health awareness among African Americans. J Health Care Poor Underserv. 2010;21(Suppl 3):132–147. doi: 10.1353/hpu.0.0357. [DOI] [PubMed] [Google Scholar]
  • 54.Tseng TS, Holt CL, Shipp M, et al. Predictors of colorectal cancer knowledge and screening among church-attending African Americans and Whites in the Deep South. J Community Health. 2009;34(2):90–97. doi: 10.1007/s10900-008-9128-2. [DOI] [PubMed] [Google Scholar]
  • 55.Lubetkin EI, Santana A, Tso A, Jia H. Predictors of cancer screening among low-income primary care patients. J Health Care Poor Underserv. 2008;19(1):135–148. doi: 10.1353/hpu.2008.0001. [DOI] [PubMed] [Google Scholar]
  • 56.Green PM, Kelly BA. Colorectal cancer knowledge, perceptions, and behaviors in African Americans. Cancer Nurs. 2004;27(3):206–215. doi: 10.1097/00002820-200405000-00004. quiz 216–217. [DOI] [PubMed] [Google Scholar]
  • 57.Morgan PD, Tyler ID, Fogel J. Fatalism revisited. Semin Oncol Nurs. 2008;24(4):237–245. doi: 10.1016/j.soncn.2008.08.003. [DOI] [PubMed] [Google Scholar]
  • 58.Kim SE, Perez-Stable EJ, Wong S, et al. Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med. 2008;168(7):728–734. doi: 10.1001/archinte.168.7.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Shokar NK, Vernon SW, Weller SC. Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population. Fam Med. 2005;37(5):341–347. [PubMed] [Google Scholar]
  • 60.Ruffin MT, Creswell JW, Jimbo M, Fetters MD. Factors influencing choices for colorectal cancer screening among previously unscreened African and Caucasian Americans: findings from a triangulation mixed methods investigation. J Community Health. 2009;34(2):79–89. doi: 10.1007/s10900-008-9133-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Powe BD, Faulkenberry R, Harmond L. A review of intervention studies that seek to increase colorectal cancer screening among African–Americans. Am J Health Promot. 2010;25(2):92–99. doi: 10.4278/ajhp.080826-LIT-162. [DOI] [PubMed] [Google Scholar]
  • 62.O’Toole J, Sinclair M, Leder K. Maximising response rates in household telephone surveys. BMC Med Res Methodol. 2008;8:71. doi: 10.1186/1471-2288-8-71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kempf AM, Remington PL. New challenges for telephone survey research in the twenty-first century. Annu Rev Public Health. 2007;28:113–126. doi: 10.1146/annurev.publhealth.28.021406.144059. [DOI] [PubMed] [Google Scholar]
  • 64.Shokar NK, Nguyen-Oghalai T, Wu H. Factors associated with a physician’s recommendation for colorectal cancer screening in a diverse population. Fam Med. 2009;41(6):427–433. [PMC free article] [PubMed] [Google Scholar]
  • 65.Rim SH, Zittleman L, Westfall JM, Overholser L, Froshaug D, Coughlin SS. Knowledge, attitudes, beliefs, and personal practices regarding colorectal cancer screening among health care professionals in rural colorado: a pilot survey. J Rural Health. 2009;25(3):303–308. doi: 10.1111/j.1748-0361.2009.00234.x. [DOI] [PubMed] [Google Scholar]
  • 66.Fisher T, Burnet D, Huang E, Chin M, Cagney K. Cultural leverage: interventions using culture to narrow racial disparities in health care. Med Care Res Rev. 2007;64(Suppl 5):S243–S282. doi: 10.1177/1077558707305414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Ward SH, Lin K, Meyer B, et al. Increasing colorectal cancer screening among African Americans, linking risk perception to interventions targeting patients, communities and clinicians. J Natl Med Assoc. 2008;100(6):748–758. doi: 10.1016/s0027-9684(15)31356-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Philip EJ, Duhamel K, Jandorf L. Evaluating the impact of an educational intervention to increase CRC screening rates in the African American community: a preliminary study. Cancer Causes Control. 2010;21:1685–1691. doi: 10.1007/s10552-010-9597-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Robillard AG, Larkey L. Health disadvantages in colorectal cancer screening among African Americans: considering the cultural context of narrative health promotion. J Health Care Poor Underserv. 2009;20(Suppl 2):102–119. doi: 10.1353/hpu.0.0161. [DOI] [PubMed] [Google Scholar]
  • 70.Thompson VL, Kalesan B, Wells A, Williams SL, Caito NM. Comparing the use of evidence and culture in targeted colorectal cancer communication for African Americans. Patient Educ Couns. 2010;81(Suppl):S22–S33. doi: 10.1016/j.pec.2010.07.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Sanders Thompson VL, Lewis T, Williams SL. Refining the use of cancer-related cultural constructs among African Americans. Health Promot Prac. 2011 doi: 10.1177/1524839911399431. (Epub ahead of print) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Siddiqui AA, Sifri R, Hyslop T, et al. Race and response to colon cancer screening interventions. Prev Med. 2011;52:262–264. doi: 10.1016/j.ypmed.2011.01.005. [DOI] [PubMed] [Google Scholar]
  • 73.Kreuter MW, Wray RJ. Tailored and targeted health communication: strategies for enhancing information relevance. Am J Health Behav. 2003;27(Suppl 3):S227–S232. doi: 10.5993/ajhb.27.1.s3.6. [DOI] [PubMed] [Google Scholar]
  • 74.Centers for Disease Control and Prevention. Cancer prevention & control: client-oriented screening interventions to increase breast, cervical, and colorectal cancer screening (archived reviews) Centers for Disease Control and Prevention; GA, USA: 2011. Guide to Community Preventive Services. [Google Scholar]
  • 75.U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion. Improvements to the Behavioral Risk Factor Surveillance System (BRFSS) Methodology, Design, and Implementation. 2006. [Google Scholar]
  • 76.Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000;9(2):229–232. [PubMed] [Google Scholar]
  • 77.Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment. Cancer Epidemiol Biomarkers Prev. 2008;17(4):777–784. doi: 10.1158/1055-9965.EPI-07-0441. [DOI] [PubMed] [Google Scholar]
  • 78.Khoja S, McGregor SE, Hilsden RJ. Validation of self-reported history of colorectal cancer screening. Can Fam Physician. 2007;53(7):1192–1197. [PMC free article] [PubMed] [Google Scholar]
  • 79.Partin MR, Grill J, Noorbaloochi S, et al. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev. 2008;17(4):768–776. doi: 10.1158/1055-9965.EPI-07-0759. [DOI] [PubMed] [Google Scholar]

Website

RESOURCES